Buscar
Congreso SOLACI
Home Tags Transcatheter aortic valve replacement

Tag: transcatheter aortic valve replacement

TAVI bajo riesgo

Evolute Low Risk at 3 Years: Promising Outcomes

solaci - 0
Sobrevida en pacientes con insuficiencia tricuspídea según variables clínicas y ecocardiográficas (Clusters)

High Implantation of Self-Expanding Valves in the Aortic Position or Cusp...

solaci - 0
By pass y actividad de la enfermedad en la arteria coronaria nativa

Clinical Impact of Coronary Artery Disease on Results After TAVR

solaci - 0

Percutaneous Access Closure in TAVR: Are Devices Similar?

solaci - 0
La prudencia es buena consejera para decidir una transfusión en el TAVI

Prosthesis Mismatch in TAVR: It’s Real Impact

solaci - 0

When Is It Best to Fracture a Bioprosthesis in TAVR?

solaci - 0

TAVR: Vascular Access in Patients with Peripheral Artery Disease, 1-Year Outcomes

solaci - 0

ACC 2023 | TAVR in Low Risk Patients: 3-Year Outcomes

solaci - 0
Buen desempeño de la Sapien 3 en “trabajos” para los que no está diseñada

Real-World Results of Different Devices for TAVR

solaci - 0
Anillos aórticos pequeños, ¿Qué válvula deberíamos elegir?

Clinical Implications of the Presence of HALT in TAVR Patients: 5-Year...

solaci - 0
123...28Page 2 of 28

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad